Skip to content

Author

J. Gascón

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Efficacy and safety of alternative benznidazole and nifurtimox regimens for adults with chronic Trypanosoma cruzi infection (TESEO): an open-label, randomised, non-inferiority phase 2b trial.

BACKGROUND Trypanosoma cruzi infection affects over seven million people worldwide. Standard-of-care benznidazole or nifurtimox causes drug-related adverse events leading to definitive treatment interruption. We evaluated whether shortened, extended, or halved-dose regimens preserve efficacy and improve tolerability....

Cristina Alonso-Vega, Jimy José Pinto Rocha, Licet Gimena Rojas Delgadillo et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.